638 related articles for article (PubMed ID: 18303280)
1. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
Prasad SR; Jagirdar J
J Comput Assist Tomogr; 2008; 32(1):1-3. PubMed ID: 18303280
[TBL] [Abstract][Full Text] [Related]
2. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor.
Moreno-Romero JA; Segura S; Mascaró JM; Cowper SE; Julià M; Poch E; Botey A; Herrero C
Br J Dermatol; 2007 Oct; 157(4):783-7. PubMed ID: 17627792
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature.
Mathur K; Morris S; Deighan C; Green R; Douglas KW
J Clin Apher; 2008; 23(4):144-50. PubMed ID: 18633995
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium and nephrogenic systemic fibrosis: association or causation.
Kurtkoti J; Snow T; Hiremagalur B
Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate.
Yerram P; Saab G; Karuparthi PR; Hayden MR; Khanna R
Clin J Am Soc Nephrol; 2007 Mar; 2(2):258-63. PubMed ID: 17699422
[TBL] [Abstract][Full Text] [Related]
6. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
Boyd AS; Sanyal S; Abraham JL
J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
[TBL] [Abstract][Full Text] [Related]
7. Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis.
Richmond H; Zwerner J; Kim Y; Fiorentino D
Arch Dermatol; 2007 Aug; 143(8):1025-30. PubMed ID: 17709661
[TBL] [Abstract][Full Text] [Related]
8. [Nephrogenic systemic fibrosis and use of MR contrast media].
Christiansen RE; Sviland L; Sekse I; Svarstad E
Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Kay J
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy).
Galan A; Cowper SE; Bucala R
Curr Opin Rheumatol; 2006 Nov; 18(6):614-7. PubMed ID: 17053507
[TBL] [Abstract][Full Text] [Related]
11. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
Broome DR
Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Hamilton-Persaud K; Ezell LD; Macklin JG
Nephrol Nurs J; 2007; 34(3):283-7; quiz 288. PubMed ID: 17644872
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic systemic fibrosis: history and epidemiology.
Thomsen HS
Radiol Clin North Am; 2009 Sep; 47(5):827-31, vi. PubMed ID: 19744597
[TBL] [Abstract][Full Text] [Related]
16. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients.
Khurram M; Skov L; Rossen K; Thomsen HS; Marckmann P
Scand J Urol Nephrol; 2007; 41(6):565-6. PubMed ID: 17934986
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
Grobner T
Nephrol Dial Transplant; 2006 Apr; 21(4):1104-8. PubMed ID: 16431890
[No Abstract] [Full Text] [Related]
18. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
Lim YL; Lee HY; Low SC; Chan LP; Goh NS; Pang SM
Clin Exp Dermatol; 2007 Jul; 32(4):353-8. PubMed ID: 17433041
[TBL] [Abstract][Full Text] [Related]
19. [Nephrogenic systemic fibrosis and gadolinium-based contrast media].
Andréjak M; Thuillier D; Lok C; Gras-Champel V
Therapie; 2007; 62(2):169-72. PubMed ID: 17582319
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
Peak AS; Sheller A
Ann Pharmacother; 2007 Sep; 41(9):1481-5. PubMed ID: 17684032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
